Literature DB >> 17425550

Negative pressure wound therapy via vacuum-assisted closure following partial foot amputation: what is the role of wound chronicity?

David G Armstrong1, Lawrence A Lavery, Andrew J M Boulton.   

Abstract

Randomised clinical trials (RCTs) to evaluate diabetic foot wound therapies have systematically eliminated large acute wounds from evaluation, focusing only on smaller chronic wounds. The purpose of this study was to evaluate the proportion and rate of wound healing in acute and chronic wounds after partial foot amputation in individuals with diabetes treated with negative pressure wound therapy (NPWT) delivered by the vacuum-assisted closure (VAC) device or with standard wound therapy (SWT). This study constitutes a secondary analysis of patients enrolled in a 16-week RCT of NPWT: 162 open foot amputation wounds (mean wound size = 20.7 cm(2)) were included. Acute wounds were defined as the wounds less than 30 days after amputation, whereas chronic wounds as the wounds greater than 30 days. Inclusion criteria consisted of individuals older than 18 years, presence of a diabetic foot amputation wound up to the transmetatarsal level and adequate perfusion. Wound size and healing were confirmed by independent, blinded wound evaluators. Analyses were done on an intent-to-treat basis. There was a significantly higher proportion of acute wounds (SWT = 59; NPWT = 63) than chronic wounds (SWT = 26; NPWT = 14), evaluated in this clinical trial (P = 0.001). There was no significant difference in the proportion of acute and chronic wounds achieving complete wound closure in either treatment group. Despite this finding, the Kaplan-Meier curves demonstrated statistically significantly faster healing in the NPWT group in both acute (P = 0.030) and chronic wounds (P = 0.033). Among the patients treated with NPWT via the VAC, there was not a significant difference in healing as a function of chronicity. In both the acute and the chronic wound groups, results for patients treated with NPWT were superior to those for the patients treated with SWT. These results appear to indicate that wound duration should not deter the clinician from using this modality to treat complex wounds.

Entities:  

Mesh:

Year:  2007        PMID: 17425550      PMCID: PMC7951344          DOI: 10.1111/j.1742-481X.2006.00270.x

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  21 in total

Review 1.  Topical negative pressure (TNP): the evolution of a novel wound therapy.

Authors:  P E Banwell; L Téot
Journal:  J Wound Care       Date:  2003-01       Impact factor: 2.072

2.  Vacuum-assisted closure: a new method for wound control and treatment: animal studies and basic foundation.

Authors:  M J Morykwas; L C Argenta; E I Shelton-Brown; W McGuirt
Journal:  Ann Plast Surg       Date:  1997-06       Impact factor: 1.539

3.  Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers.

Authors:  G D Gentzkow; S D Iwasaki; K S Hershon; M Mengel; J J Prendergast; J J Ricotta; D P Steed; S Lipkin
Journal:  Diabetes Care       Date:  1996-04       Impact factor: 19.112

4.  Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial.

Authors:  A Veves; V Falanga; D G Armstrong; M L Sabolinski
Journal:  Diabetes Care       Date:  2001-02       Impact factor: 19.112

5.  Electric stimulation as an adjunct to heal diabetic foot ulcers: a randomized clinical trial.

Authors:  E J Peters; L A Lavery; D G Armstrong; J G Fleischli
Journal:  Arch Phys Med Rehabil       Date:  2001-06       Impact factor: 3.966

Review 6.  Preventing foot ulcers in patients with diabetes.

Authors:  Nalini Singh; David G Armstrong; Benjamin A Lipsky
Journal:  JAMA       Date:  2005-01-12       Impact factor: 56.272

7.  Diabetic neuropathic foot ulcers: predicting which ones will not heal.

Authors:  David J Margolis; Lynne Allen-Taylor; Ole Hoffstad; Jesse A Berlin
Journal:  Am J Med       Date:  2003-12-01       Impact factor: 4.965

8.  The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study.

Authors:  M J Young; J L Breddy; A Veves; A J Boulton
Journal:  Diabetes Care       Date:  1994-06       Impact factor: 19.112

9.  A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers.

Authors:  Aristidis Veves; Peter Sheehan; Hau T Pham
Journal:  Arch Surg       Date:  2002-07

10.  Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group.

Authors:  D L Steed
Journal:  J Vasc Surg       Date:  1995-01       Impact factor: 4.268

View more
  11 in total

Review 1.  Diabetic Foot Infections: Update on Management.

Authors:  Maria Nikoloudi; Ioanna Eleftheriadou; Anastasios Tentolouris; Ourania A Kosta; Nikolaos Tentolouris
Journal:  Curr Infect Dis Rep       Date:  2018-08-01       Impact factor: 3.725

Review 2.  Polymicrobial interactions: impact on pathogenesis and human disease.

Authors:  Brian M Peters; Mary Ann Jabra-Rizk; Graeme A O'May; J William Costerton; Mark E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

Review 3.  The care of transmetatarsal amputation in diabetic foot gangrene.

Authors:  Michele Ammendola; Rosario Sacco; Lucia Butrico; Giuseppe Sammarco; Stefano de Franciscis; Raffaele Serra
Journal:  Int Wound J       Date:  2016-10-03       Impact factor: 3.315

Review 4.  A systematic review of the effectiveness of negative pressure wound therapy in the management of diabetes foot ulcers.

Authors:  Georgia Noble-Bell; Angus Forbes
Journal:  Int Wound J       Date:  2008-06       Impact factor: 3.315

5.  Use of a Nanoflex powder dressing for wound management following debridement for necrotising fasciitis in the diabetic foot.

Authors:  Ryan H Fitzgerald; Manish Bharara; Joseph L Mills; David G Armstrong
Journal:  Int Wound J       Date:  2009-04       Impact factor: 3.315

Review 6.  Management of diabetic foot: Brief synopsis for busy orthopedist.

Authors:  Tae Hwan Park; Ashish Anand
Journal:  J Clin Orthop Trauma       Date:  2014-11-14

7.  Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus.

Authors:  Zhenmi Liu; Jo C Dumville; Robert J Hinchliffe; Nicky Cullum; Fran Game; Nikki Stubbs; Michael Sweeting; Frank Peinemann
Journal:  Cochrane Database Syst Rev       Date:  2018-10-17

8.  Effects of limited access dressing in chronic wounds: A biochemical and histological study.

Authors:  Thittamaranahalli Muguregowda Honnegowda; Pramod Kumar; E G Padmanabha Udupa; Anurag Sharan; Rekha Singh; Hemanth K Prasad; Pragna Rao
Journal:  Indian J Plast Surg       Date:  2015 Jan-Apr

9.  Effect of limited access dressing on hydroxyproline and enzymatic antioxidant status in nonhealing chronic ulcers.

Authors:  Thittamaranahalli Muguregowda Honnegowda; Pramod Kumar; Padmanabha Udupa; Pragna Rao; Siddhartha Bhandary; Krishna Kumar Mahato; Anurag Sharan; Shreemathi S Mayya
Journal:  Indian J Plast Surg       Date:  2014-05

10.  Incisional negative pressure wound therapy dressings (iNPWTd) in routine primary hip and knee arthroplasties: A randomised controlled trial.

Authors:  S L Karlakki; A K Hamad; C Whittall; N M Graham; R D Banerjee; J H Kuiper
Journal:  Bone Joint Res       Date:  2016-08       Impact factor: 5.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.